BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28468016)

  • 1. Treating Hepatobiliary Cancers: The Oncology Way.
    Galle PR
    Dig Dis; 2017; 35(4):384-386. PubMed ID: 28468016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
    Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
    Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcentimetric Incidental Intrahepatic Cholangiocarcinoma in an Explant Liver: Diagnostic Difficulty of a Rare Entity.
    Mitra S; Geethanjali G; Rathi S; Behera A; Das A
    Int J Surg Pathol; 2018 Dec; 26(8):739-744. PubMed ID: 29742944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
    Sasaki M; Sato Y; Nakanuma Y
    Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapies for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Current and developing strategies.
    Argemi J; Ponz-Sarvise M; Sangro B
    Adv Cancer Res; 2022; 156():367-413. PubMed ID: 35961706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-viral serology uncovers distinct virome patterns as risk predictors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Do WL; Wang L; Forgues M; Liu J; Rabibhadana S; Pupacdi B; Zhao Y; Gholian H; Bhudhisawasdi V; Pairojkul C; Sukeepaisarnjaroen W; Pugkhem A; Luvira V; Lertprasertsuke N; Chotirosniramit A; Auewarakul CU; Ungtrakul T; Sricharunrat T; Sangrajrang S; Phornphutkul K; Budhu A; Harris CC; Mahidol C; Ruchirawat M; Wang XW
    Cell Rep Med; 2023 Dec; 4(12):101328. PubMed ID: 38118412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary cancers, version 2.2014.
    Benson AB; D'Angelica MI; Abrams TA; Are C; Bloomston PM; Chang DT; Clary BM; Covey AM; Ensminger WD; Iyer R; Kelley RK; Linehan D; Malafa MP; Meranze SG; Park JO; Pawlik T; Posey JA; Scaife C; Schefter T; Sigurdson ER; Tian GG; Vauthey JN; Venook AP; Yen Y; Zhu AX; Hoffmann KG; McMillian NR; Sundar H
    J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor ratio of unsaturated to saturated sulfatide species is associated with disease-free survival in intrahepatic cholangiocarcinoma.
    Huizing L; Chen L; Roeth AA; Heij LR; Flinders B; Bouwense SAW; Balluff B; Neumann UP; Heeren RMA; Olde Damink SWM; Vreeken RJ; Schaap FG
    Cell Oncol (Dordr); 2023 Jun; 46(3):629-642. PubMed ID: 36630049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers.
    Lee CH; Hsieh SY; Chang CJ; Lin YJ
    J Gastroenterol Hepatol; 2013 Jan; 28(1):122-7. PubMed ID: 23034166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Pomyen Y; Chaisaingmongkol J; Rabibhadana S; Pupacdi B; Sripan D; Chornkrathok C; Budhu A; Budhisawasdi V; Lertprasertsuke N; Chotirosniramit A; Pairojkul C; Auewarakul CU; Ungtrakul T; Sricharunrat T; Phornphutkul K; Sangrajang S; Loffredo CA; Harris CC; Mahidol C; Wang XW; Ruchirawat M;
    Sci Rep; 2023 Jul; 13(1):11406. PubMed ID: 37452065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental Intra-Hepatic Cholangiocarcinoma and Hepatocholangiocarcinoma in Liver Transplantation: A Single-Center Experience.
    Serra V; Tarantino G; Guidetti C; Aldrovandi S; Cuoghi M; Olivieri T; Assirati G; De Ruvo N; Magistri P; Ballarin R; Di Benedetto F
    Transplant Proc; 2016 Mar; 48(2):366-9. PubMed ID: 27109957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidence-based management of primary liver cancers: cholangiocarcinoma.].
    Alvaro D; Bragazzi MC; Venere R; Ridola L
    Recenti Prog Med; 2021 Feb; 112(2):117-123. PubMed ID: 33624624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrahepatic cholangiocarcinoma biomarkers: Towards early detection and personalized pharmacological treatments.
    Capuozzo M; Santorsola M; Ferrara F; Cinque C; Farace S; Patrone R; Granata V; Zovi A; Nasti G; Ottaiano A
    Mol Cell Probes; 2024 Feb; 73():101951. PubMed ID: 38244704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in Diagnosing and Reporting Cholangiocarcinoma.
    El Jabbour T; Molnar A; Lagana SM
    Surg Pathol Clin; 2023 Sep; 16(3):599-608. PubMed ID: 37536891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of socio-economic environment on incidence of primary liver cancer in France between 2006 and 2016.
    Comoz B; Ollivier-Hourmand I; Bouvier AM; Nousbaum JB; Nguyen TTN; Launoy G; Bouvier V; Bryere J
    Liver Int; 2024 Feb; 44(2):446-453. PubMed ID: 38010978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Component with abundant immune-related cells in combined hepatocellular cholangiocarcinoma identified by cluster analysis.
    Yagi N; Suzuki T; Mizuno S; Kojima M; Kudo M; Sugimoto M; Kobayashi S; Gotohda N; Ishii G; Nakatsura T
    Cancer Sci; 2022 May; 113(5):1564-1574. PubMed ID: 35226764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of Acylphosphatase 1 Expression in Combined HCC-iCCA, HCC, and iCCA.
    Sakano Y; Noda T; Kobayashi S; Kitagawa A; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Gotoh K; Asaoka T; Tanemura M; Umeshita K; Mimori K; Doki Y; Eguchi H
    Dig Dis Sci; 2022 Aug; 67(8):3817-3830. PubMed ID: 34626299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.